Nurtec release date?

Q: Nurtec release date?

Nurtec ODT (rimegepant) – First U.S. FDA approval and release Region Approval / Release Date Notes United States February 26 , 2019 (FDA approval) Commercial launch followed shortly thereafter, with the product available to patients and prescribers in March 2019. United Kingdom July 2019 (MHRA approval) Market launch a few months later. European Union (other member states) 2019 (EMA approval in June 2019) Availability in national markets varied, generally beginning late‑2019. Japan 2018 (approval by PMDA) First marketed as “Rimegepant” in Japan prior to U.S. launch. Key points The U.S. approval on Feb 26 2019 marked the first time the drug was cleared for use as an acute migraine treatment. The FDA approval was based on Phase III clinical trials showing a significant reduction in migraine pain and associated symptoms compared to placebo. Post‑approval, the drug is marketed as Nurtec ODT (or simply “Nurtec”) and is available over‑the‑counter in the U.S. after the FDA’s “expanded access” program. If you’re interested in a specific country outside the above list or need details on the drug’s market availability in a particular region, just let me know!

Question

Accepted Answer

Nurtec ODT (rimegepant) – First U.S. FDA approval and release

Region	Approval / Release Date	Notes
United States	February 26 , 2019 (FDA approval)	Commercial launch followed shortly thereafter, with the product available to patients and prescribers in March 2019.
United Kingdom	July 2019 (MHRA approval)	Market launch a few months later.
European Union (other member states)	2019 (EMA approval in June 2019)	Availability in national markets varied, generally beginning late‑2019.
Japan	2018 (approval by PMDA)	First marketed as “Rimegepant” in Japan prior to U.S. launch.

Key points

The U.S. approval on Feb 26 2019 marked the first time the drug was cleared for use as an acute migraine treatment.
The FDA approval was based on Phase III clinical trials showing a significant reduction in migraine pain and associated symptoms compared to placebo.
Post‑approval, the drug is marketed as Nurtec ODT (or simply “Nurtec”) and is available over‑the‑counter in the U.S. after the FDA’s “expanded access” program.

If you’re interested in a specific country outside the above list or need details on the drug’s market availability in a particular region, just let me know!

Ask Questions, Get Industry Insights … Instantly

Recent Questions

Nurtec release date?